STAND.
COM. REP. NO. 2015
Honolulu, Hawaii
RE: GOV. MSG. NOS. 603, 619, 620
Honorable Ronald D. Kouchi
President of the Senate
Thirty-Second State Legislature
Regular Session of 2023
State of Hawaii
Sir:
Your Committee on Commerce and Consumer Protection, to which was referred Governor's Message Nos. 603, 619, and 620, submitting for study and consideration the nominations of:
Board of Pharmacy
|
G.M. No. 603 |
BRANDON RABANG, for a term to expire 06-30-2026; |
|
G.M. No. 619 |
PATRICK ADAMS, for a term to expire 06-30-2027; and |
|
G.M. No. 620 |
CATALINA CROSS, for a term to expire 06-30-2027, |
begs leave to report as follows:
BRANDON RABANG
Upon review of the testimony, your Committee finds that Mr. Rabang's experience, background, and commitment to public service qualify him for appointment to the Board of Pharmacy as a public member. Your Committee notes that Mr. Rabang is currently an Executive Hybrid Territory Specialist and Direct Sales Trainer for Janssen Pharmaceutical, Inc. where he is responsible for achieving sales quota and business objectives within the Hawaii region. During the course of Mr. Rabang's career, he has gained broad experience and knowledge about the pharmaceutical industry pertaining to cardiovascular and internal medicine and has developed relationships with physicians, medical practices and staff, hospitals, hospital networks, clinics, purchasing departments, pharmacies, and other pertinent stakeholders. Your Committee further notes that Mr. Rabang has served as an interim member of the Board of Pharmacy since 2022 and has a thorough understanding of the roles and responsibilities of its members. Your Committee therefore recommends that Brandon Rabang be appointed to the Board of Pharmacy based on his knowledge, experience, and commitment to public service.
PATRICK ADAMS
Your Committee received testimony in support of the nomination for the reappointment of Patrick Adams from the Board of Pharmacy and one individual. Your Committee received testimony in opposition to the nomination for the reappointment of Patrick Adams from one individual. Your Committee notes that the testimony submitted in opposition to this nominee contained no substantive information or commentary relating to his appointment.
Upon review of the testimony, your Committee finds that Mr. Adams's background, knowledge, and proven leadership on the Board of Pharmacy qualify him for reappointment to the Board as a pharmacist member. Your Committee notes that Mr. Adams has over twenty years of experience in pharmacy and was most recently the Director of Pharmacy at Malama Compounding Pharmacy. Prior to that, Mr. Adams served as the Director of Pharmacy at Foodland Supermarkets; the Community Affairs Director at the University of Hawaii at Hilo, Daniel K. Inouye College of Pharmacy; and a pharmacy manager in Washington and Hawaii. Mr. Adams has also received additional education as a pharmacist to perform specialized duties and holds national qualifications and certificates to train pharmacists in various areas. Your Committee further finds that Mr. Adams has served on the Board of Pharmacy since 2020 and his experience and knowledge will continue to be assets to the Board of Pharmacy. Your Committee therefore recommends that Patrick Adams be reappointed to the Board of Pharmacy based on his experience, background, and dedication to public service.
CATALINA CROSS
Your Committee received testimony in support of the nomination for the reappointment of Catalina Cross from the Board of Pharmacy; First Vitals Health and Wellness, Inc.; and four individuals. Your Committee received testimony in opposition to the nomination for the reappointment of Catalina Cross from one individual. Your Committee notes that the testimony submitted in opposition to this nominee contained no substantive information or commentary relating to her appointment.
Upon review of the testimony, your Committee finds that Dr. Cross's knowledge, experience, and dedication to community service qualify her for reappointment to the Board of Pharmacy as a public member. Your Committee notes that Dr. Cross holds a Ph.D. in Public Policy and Administration and is the current General Manager for Pharmacare Hawaii, where she develops and implements strategies to increase financial growth of retail pharmacy and third party administrator services. Dr. Cross is also a member of the National Community Pharmacists Association; was previously a co-chair of Maui Community Health Partners; and Dean's Council Member of the University of Hawaii at Hilo, Daniel K. Inouye College of Pharmacy. Your Committee further finds that Dr. Cross has served on the Board of Pharmacy since 2019 and her knowledge and experience as a public member will continue to enhance the effectiveness of the Board of Pharmacy. Your Committee therefore recommends that Catalina Cross be reappointed to the Board of Pharmacy based on her background, knowledge, and continued desire to serve her community.
As affirmed by the records of votes of the members of your Committee on Commerce and Consumer Protection that are attached to this report, your Committee, after full consideration of the background, experience, and qualifications of the nominees, has found the nominees to be qualified for the positions to which nominated and recommends that the Senate advise and consent to the nominations.
Respectfully submitted on behalf of the members of the Committee on Commerce and Consumer Protection,
|
|
|
____________________________ JARRETT KEOHOKALOLE, Chair |
|
|
|
|